Renal matrix metalloproteinase activity is unaffected by experimental ischemia-reperfusion injury and matrix metalloproteinase inhibition does not alter outcome of renal functionZISWILER, Ruth; DANIEL, Catherine; FRANZ, Eva et al.Experimental nephrology. 2001, Vol 9, Num 2, pp 118-124, issn 1018-7782Article

A subset of metzincins and related genes constitutes a marker of human solid organ fibrosisRÖDDER, Silke; SCHERER, Andreas; KÖRNER, Meike et al.Virchows Archiv. 2011, Vol 458, Num 4, pp 487-496, issn 0945-6317, 10 p.Article

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockadeFERRARI, Paolo; MARTI, Hans-Peter; PFISTER, Marc et al.Journal of hypertension. 2002, Vol 20, Num 1, pp 125-130, issn 0263-6352Article

The Production of Non-Planar Coils for the Wendelstein 7-X Experiment : A (Self-) Critical ReviewSCHELLER, Holger; HEYN, Katrin; MARTI, Hans Peter et al.IEEE transactions on applied superconductivity. 2008, Vol 18, Num 2, pp 451-454, issn 1051-8223, 4 p.Conference Paper

Wiedereinfùhrung des Non-Heart-Beating-Donor-Programms in der Schweiz ? = Réintroduction du Non-Heart-Beating-Donor Programm en Suisse ?BEYELER, Franziska; WALCHLI-BHEND, Susanna; MARTI, Hans-Peter et al.BULLETIN DES MEDECINS SUISSES. 2009, Vol 90, Num 23, pp 899-901, issn 1661-5948, 3 p.Article

Drug targeting using OX7-immunoliposomes : Correlation between Thy1.1 antigen expression and tissue distribution in the ratTUFFIN, Gerald; HUWYLER, Jörg; WAELTI, Ernst et al.Journal of drug targeting. 2008, Vol 16, Num 2, pp 156-166, issn 1061-186X, 11 p.Article

The willingness of patients to accept an additional mortality risk in order to improve renal graft survivalGIRARDI, Vincenzo; SCHAEDELI, Franziska; MARTI, Hans-Peter et al.Kidney international. 2004, Vol 66, Num 1, pp 375-382, issn 0085-2538, 8 p.Article

Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipientsSCHÄDELI, Franziska; MARTI, Hans-Peter; FREY, Felix J et al.Clinical pharmacokinetics. 2002, Vol 41, Num 1, pp 59-69, issn 0312-5963Article

Reduced 11β-hydroxysteroid dehydrogenase activity in experimental nephrotic syndromeVOGT, Bruno; DICK, Bernhard; MARTI, Hans-Peter et al.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, Num 5, pp 753-758, issn 0931-0509Article

Intrarenal arterial aneurysms with haematuria in a patient with tuberous sclerosis complexKÜNZI, Thomas; WALTHER, Frank; MARTI, Hans-Peter et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 10, pp 2268-2270, issn 0931-0509, 3 p.Article

Immunoliposome targeting to mesangial cells : A promising strategy for specific drug delivery to the kidneyTUFFIN, Gérald; WAELTI, Ernst; HUWYLER, Jörg et al.Journal of the American Society of Nephrology. 2005, Vol 16, Num 11, pp 3295-3305, issn 1046-6673, 11 p.Article

Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritisLODS, Nadège; FERRARI, Paolo; FREY, Felix J et al.Journal of the American Society of Nephrology. 2003, Vol 14, Num 11, pp 2861-2872, issn 1046-6673, 12 p.Article

Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidismSERRA, Andreas L; SCHWARZ, Albin A; WICK, Franziska H et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 7, pp 1315-1319, issn 0931-0509, 5 p.Article

Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine eraMARTI, Hans-Peter; HENSCHKOWSKI, Jana; LAUX, Gunter et al.Transplant international. 2006, Vol 19, Num 1, pp 19-26, issn 0934-0874, 8 p.Article

Urinary Soluble HLA-DR Is a Potential Biomarker for Acute Renal Transplant RejectionYI TIAN TING; TOBY COATES, P; MARTI, Hans-Peter et al.Transplantation. 2010, Vol 89, Num 9, pp 1071-1078, issn 0041-1337, 8 p.Article

Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipientsFERRARI, Paolo; SCHROEDER, Verena; ANDERSON, Suzanne et al.Transplantation. 2002, Vol 74, Num 8, pp 1147-1152, issn 0041-1337Article

Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney diseaseBERTHIER, Céline C; WAHL, Patricia R; LE HIR, Michel et al.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 3, pp 880-889, issn 0931-0509, 10 p.Article

Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohortKOLLER, Michael T; VAN DELDEN, Christian; MEYLAN, Pascal et al.European journal of epidemiology. 2013, Vol 28, Num 4, pp 347-355, issn 0393-2990, 9 p.Article

De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases. CommentaryCREW, R. John; RADHAKRISHNAN, Jai; COHEN, David J et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 1, pp 13-15, issn 0931-0509, 10 p.Article

Prophylactic hemodialysis after radiocontrast media in patients with Renal insufficiency is potentially harmfulVOGT, Bruno; FERRARI, Paolo; FREY, Felix J et al.The American journal of medicine. 2001, Vol 111, Num 9, pp 692-698, issn 0002-9343Article

Comparison of continuous and intermittent renal replacement therapy for acute renal failureUEHLINGER, Dominik E; JAKOB, Stephan M; TAKALA, Jukka et al.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, Num 8, pp 1630-1637, issn 0931-0509, 8 p.Article

Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantationFANGMANN, Josef; ARNS, Wolfgang; FARESE, Stefan et al.Nephrology, dialysis, transplantation (Print). 2010, Vol 25, Num 1, pp 283-292, issn 0931-0509, 10 p.Article